Editorial Volume 9, Issue 8 pp 1847—1848
Targeting NFκB signaling in GD2+ BCSCs
- 1 Section of Molecular Hematology and Therapy, Leukemia Department, UT MD Anderson Cancer Center, Houston, TX 77030, USA
- 2 Department of Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, TX 77030, USA
received: August 1, 2017 ; published: August 3, 2017 ;https://doi.org/10.18632/aging.101274
How to Cite
Copyright: Nguyen and Battula. This is an open‐access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.